Takako Araki, MD

Dr. Takako Araki graduated from Nagasaki University School of Medicine in Nagasaki, Japan. She completed her Internal Medicine residency training and Endocrinology fellowship from Mount Sinai Beth Israel, NY. She also completed her postdoctoral and clinical fellow ship from Cedars-Sinai Medical Center, Los Angeles, CA in 2015. Dr. Araki is currently an Assistant Professor in Division of Endocrinology, Diabetes and Metabolism at University of Minnesota. Her research is focused on quality improvement of pituitary perioperative patient care and pituitary/neuroendocrine hormone regulations.

• NIH T32 Training Grant (Melmed PI) (2013)
• Friedman Research Fellowship, Friedman Foundation, NY, USA (2008)
• Mitsui Awards for Young Japanese Physicians in the USA, Japanese Medical Society of America, NY, USA (2008)
• N Program Scholar Award, Tokio Marine Foundation, Tokyo, Japan (2008)

• North American Skull Base Society
• Member, Pituitary Society
• Member, Endocrine Society

• Gene regulations of pituitary/neuroendocrine tumors
• Quality Improvement of Pituitary Preoperative Patient Care

• Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A, Yamada S, Takeshita A, Yamamoto M, Kawakami Y, Tone M, Melmed S. Two Distinctive POMC Promoters Modify Gene Expression in Cushing's Disease. J Clin Endocrinol Metab. 2021 Jun 1, PubMed PMID: 34061962.
• Araki T, Sangtian J, Ruanpeng D, Tummala R, Clark B, Burmeister L, Peterson D, Venteicher AS, Kawakami Y. Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease. Pituitary. 2021 May 26, PubMed PMID: 34041660
• Araki T, Liu X, Kameda H, Tone Y, Fukuoka H, Tone M, Melmed S. EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.J. Endocr. Soc. (2017) 1(2): 127-143.
• Araki T, Liu NA, Tone Y, Cuevas-Ramos D, Heltsley R, Tone M, Melmed S. E2F1-mediated human POMC expression in ectopic Cushing’s syndrome.Endocr Relat Cancer.(2016) 23(11):857-87
• Liu NA*Araki T* (co-first), Cuevas-Ramos D, Hong J, Ben-Shlomo A, Tone Y, Tone M, Melmed S. Cyclin E-mediated human proopiomelanocortin regulation as a therapeutic target for Cushing disease.J Clin Endocrinol Metab.(2015) 100(7):2557-64.